Home/Filings/4/0001209191-22-014395
4//SEC Filing

Lecault Veronique 4

Accession 0001209191-22-014395

CIK 0001703057other

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 7:49 PM ET

Size

7.9 KB

Accession

0001209191-22-014395

Insider Transaction Report

Form 4
Period: 2022-02-28
Lecault Veronique
DirectorChief Technology Officer
Transactions
  • Purchase

    Common Shares

    2022-02-28$8.66/sh+230,789$1,998,6331,570,122 total
Holdings
  • Common Shares

    (indirect: See Footnote)
    7,155,008
  • Common Shares

    (indirect: See Footnote)
    273,630
  • Common Shares

    (indirect: By Spouse)
    61,580
Footnotes (3)
  • [F1]The price reported in Column 4 is a weighted average price. The shares were purchased at prices ranging from $8.48 to $8.80. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F2]These shares are held by Pacific Swell Capital Corp ("Pacific Swell"). The Reporting Person is a director of Pacific Swell and shares voting and dispositive power with respect to the shares held by Pacific Swell. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of her indirect pecuniary interest therein.
  • [F3]These shares are held by Slomo Family Trust. The Reporting Person is a co-trustee of the Slomo Family Trust. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of her indirect pecuniary interest therein.

Issuer

AbCellera Biologics Inc.

CIK 0001703057

Entity typeother

Related Parties

1
  • filerCIK 0001834418

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 7:49 PM ET
Size
7.9 KB